Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Medicinova Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −2 vs. Q2 2024
- Shares held
- 4.93M
- +837.2K (+20.5%) vs. Q2 2024
- Total value
- $10.4M
- +$4.32M (+71.4%) vs. Q2 2024
- New holders
- 4
- 5 more added
- Sold out
- 6
- 11 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2.32M | 0.66% | 00.0% | Unchanged |
| BlackRock, Inc. | 700,578 | $1.47M | 0.00% | +700,578 | New |
| Vanguard Group Inc | 623,333 | $1.31M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 505,966 | $1.06M | 0.00% | +47,201+10.3% | Added |
| Citigroup Inc | 447,957 | $940.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 305,489 | $641.5K | 0.00% | +305,340+204,926.2% | Added |
| Renaissance Technologies LLC | 186,600 | $391.9K | 0.00% | −23,400−11.1% | Reduced |
| State Street Corp | 157,198 | $330.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 145,147 | $304.8K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 141,012 | $296.1K | 0.00% | −4,883−3.3% | Reduced |
| Bank of New York Mellon Corp | 96,174 | $202.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 82,800 | $173.9K | 0.00% | −400−0.5% | Reduced |
| Bank of America Corp | 76,349 | $160.3K | 0.00% | −42,312−35.7% | Reduced |
| Charles Schwab Investment Management Inc | 71,506 | $150.2K | 0.00% | −63,287−47.0% | Reduced |
| Dimensional Fund Advisors LP | 61,285 | $128.7K | 0.00% | −8,087−11.7% | Reduced |
| Susquehanna International Group, LLP | 56,999 | $119.7K | 0.00% | +45,800+409.0% | Added |
| Schonfeld Strategic Advisors LLC | 41,100 | $86.3K | 0.00% | −600−1.4% | Reduced |
| Price T Rowe Associates Inc | 20,700 | $44.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 20,453 | $43.0K | 0.00% | −4,433−17.8% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 16,027 | $39.9K | 0.00% | −1,046−6.1% | Reduced |
| Jane Street Group, LLC | 14,138 | $29.7K | 0.00% | +14,138 | New |
| WealthTrust Axiom LLC | 12,500 | $26.3K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11,276 | $23.7K | 0.00% | +5,900+109.7% | Added |
| Goldman Sachs Group Inc | 10,246 | $21.5K | 0.00% | +10,246 | New |
| Buckingham Strategic Partners | 10,000 | $21.0K | 0.00% | +10,000 | New |
| Hantz Financial Services, Inc. | 4,300 | $9.00K | 0.00% | +2,500+138.9% | Added |
| Tower Research Capital LLC (TRC) | 2,321 | $4.87K | 0.00% | −4,208−64.5% | Reduced |
| Citadel Advisors LLC | 1,431 | $3.00K | 0.00% | −16,798−92.1% | Reduced |
| BNP Paribas Arbitrage, SA | 412 | $865 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 305 | $641 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −132,230−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |